Abstract
Background
With recent improvements in breast imaging, our ability to identify small breast tumors has markedly improved, prompting significant interest in the use of ablation without surgical excision to treat early-stage breast cancer. We conducted a multi-institutional pilot safety study of cryoablation in the treatment of primary breast carcinomas.
Methods
Twenty-nine patients with ultrasound-visible primary invasive breast cancer ≤2.0 cm were enrolled. Twenty-seven (93%) successfully underwent ultrasound-guided cryoablation with a tabletop argon gas-based cryoablation system with a double freeze/thaw cycle. Standard surgical resection was performed 1 to 4 weeks after cryoablation. Patients were monitored for complications, and pathology data were used to assess efficacy.
Results
Cryoablation was successfully performed in an office-based setting with only local anesthesia. There were no complications to the procedure or postprocedural pain requiring narcotic pain medications. Cryoablation successfully destroyed 100% of cancers <1.0 cm. For tumors between 1.0 and 1.5 cm, this success rate was achieved only in patients with invasive ductal carcinoma without a significant ductal carcinoma-in-situ (DCIS) component. For unselected tumors >1.5 cm, cryoablation was not reliable with this technique. Patients with noncalcified DCIS were the cause of most cryoablation failures.
Conclusions
Cryoablation is a safe and well-tolerated office-based procedure for the ablation of early-stage breast cancer. At this time, cryoablation should be limited to patients with invasive ductal carcinoma ≤1.5 cm and with <25% DCIS in the core biopsy. A multicenter phase II clinical trial is planned.
Similar content being viewed by others
REFERENCES
Jemal A, Tiwari RC, Murray T, et al. Cancer statistics 2004. CA Cancer J Clin 2004;54:8–29.
Fisher B, Redmond C, Poisson R, et al. Eight-year results of a randomized clinical trial comparing total mastectomy and lumpectomy with or without irradiation in the treatment of breast cancer. N Engl J Med 1989;320:822–8.
Cady B, Stone MD, Schuler JG, et al. The new era in breast cancer: invasion, size and nodal involvement dramatically decreasing as a result of mammographic screening. Arch Surg 1996;131:301–8.
Jeffrey SS, Birdwell RL, Ikeda DM, et al. Radiofrequency ablation of breast cancer. First report of an emerging technology. Arch Surg 1999;134:1064–8.
Izzo F, Thomas R, Delrio P, et al. Radiofrequency ablation in patients with primary breast carcinoma. A pilot study in 26 patients. Cancer 2001;92:2036–44.
Singletary SE. Minimally invasive ablation techniques in breast cancer treatment (editorial). Ann Surg Oncol 2002;9:319–20.
Singletary SE, Fornage BD, Sneige N, et al. Radiofrequency ablation of early-stage invasive breast tumors: an overview. Cancer J 2002;8:177–80.
Staren ED, Sabel MS, Gianakakis LM, et al. Cryosurgery of breast cancer. Arch Surg 1997;132:28–33.
Pfleiderer SO, Freesmeyer MG, Marx C, et al. Cryotherapy of breast cancer under ultrasound guidance: initial results and limitations. Eur Radiol 2002;12:3009–14.
Robinson DS, Parel J-M, Denham DB, et al. Interstitial laser hyperthermia model development for minimally invasive therapy of breast carcinoma. J Am Coll Surg 1998;186:284–92.
Robinson DS, Parel J-M, Denham DB, et al. Stereotactic uses beyond core biopsy: model development for minimally invasive treatment of breast cancer through interstitial laser hyperthermia. Am Surg 1996;62:117–8.
Harries SA, Amin Z, Smith ME, et al. Interstitial laser photocoagulation as a treatment for breast cancer. Br J Surg 1994;81:1617–9.
Dowlatshahi K, Bauich D, Kluiber R. Histologic evaluation of rat mammary tumor necrosis by interstitial Nd: YAG laser hyperthermia. Lasers Surg Med 1992;12:159–64.
Dowlatshahi K, Fan M, Gould VE, et al. Stereotactically guided laser therapy of occult breast tumors: work in progress report. Arch Surg 2000;135:1345–52.
Dowlatshahi K, Francescatti DS, Bloom KJ. Laser therapy for small breast cancers. Am J Surg 2002;184:359–63.
Mumtaz H, Hall-Graggs MA, Wotherspoon A, et al. Laser therapy for breast cancer: MR imaging and histopathologic correlation. Radiology 1996;200:651–8.
Harms SE. MR-guided minimally invasive procedures. Magn Reson Imaging Clin N Am 2001;9:381–92.
Hill CR, ter Haar GR. High intensity focused ultrasound—potential for cancer treatment. Br J Radiol 1995;68:1296–303.
ter Haar GR. Ultrasound focal beam surgery. Ultrasound Med Biol 1995;21:1089–100.
Bohris C, Jenne JW, Rastert R, et al. MR monitoring of focused ultrasound surgery (FUS) in a breast tissue model. Magn Reson Imaging 2001;19:167–75.
Hynynen K, Darkazanli A, Unger E, Schenck JF. MRI-guided noninvasive ultrasound surgery. Med Phys 1993;20:107–15.
Chung AH, Jolesz FA, Hynyen K. Thermal dosimetry of a focused ultrasound beam in vivo by magnetic resonance imaging. Med Phys 1999;26:2017–26.
Graham SJ, Chen L, Leitch M, et al. Quantifying tissue damage due to focused ultrasound heating observed by MRI. Magn Reson Med 1999;41:321–8.
Hynynen K, Pomeroy O, Smith DN, et al. MR Imaging-guided focused ultrasound surgery of fibroadenomas in the breast: a feasibility study. Radiology 2001;219:176–85.
Huber PE, Jenne JW, Rastert R, et al. A new non-invasive approach in breast cancer therapy using magnetic resonance imaging guided focused ultrasound surgery. Cancer Res 2001;61:8441–7.
Chaudhary SS, Mishra RK, Swarup A, Thomas JM. Dielectric properties of normal and malignant human breast tissue at radiowave and microwave frequencies. Indian J Biochem Biophys 1984;21:76–9.
Joines WT, Zhang Y, Li C, Jirtle RL. The measured electrical properties of normal and malignant human tissues from 50 to 900 MHz. Med Phys 1994;21:547–50.
Campbell AM, Land DV. Dielectric properties of female human breast tissue measured in vitro at 3.2 GHz. Phys Med Biol 1992;37:193–210.
Gardner RA, Vargas HI, Block JB, et al. Focused microwave phased array thermotherapy for primary breast cancer. Ann Surg Oncol 2002;9:326–32.
Ravikumar TS. The role of cryotherapy in the management of patients with liver tumors. Adv Surg 1997;30:281–91.
Weaver ML, Ashton JG, Zemel R. Treatment of colorectal liver metastases by cryotherapy. Semin Surg Oncol 1998;14:167–70.
Gage AA, Huben R. Cryosurgical ablation of the prostate. Urol Oncol 2000;5:11–9.
Onik GM, Cohen J, Reyes G, et al. Transrectal ultrasound-guided percutaneous radical cryoablation of the prostate. Cancer 1993;72:1291–9.
Uchida M, Imaide Y, Sugimoto K, et al. Percutaneous cryosurgery for renal tumors. Br J Urol 1995;75:132–5.
Rukstalis D, Khorsandi M, Garcia F, et al. Clinical experience with renal cryoablation. Urology 2001;57:34–9.
Suzuki Y. Cryosurgical treatment of advanced breast cancer and cryoimmunological responses. Skin Cancer 1995;10:19–26.
Tanaka S. Cryosurgical treatment of advanced breast cancer. Skin Cancer 1995;10:9–18.
Kaufman CS, Bachman B, Littrup PJ, et al. Office-based ultrasound-guided cryoablation of breast fibroadenomas. Am J Surg 2002;184:394–400.
Rabin Y, Julian TB, Olson P, et al. Long-term follow-up post-cryosurgery in a sheep breast model. Cryobiology 1999;39:29–46.
Rui J, Tatsutani KN, Dahiya R, Rubinsky B. Effect of thermal variables on human breast cancer in cryosurgery. Breast Cancer Res Treat 1999;53:185–92.
Rand RW, Rand RP, Eggerding FA, et al. Cryolumpectomy for breast cancer: an experimental study. Cryobiology 1985;22:307–18.
Neel HB, Ketcham AS, Hammond WG. Requisites for successful cryogenic surgery of cancer. Arch Surg 1971;102:45–8.
Gage AA. History of cryosurgery. Semin Surg Oncol 1998;14:99–109.
Bird HM. James Arnott, MD (Aberdeen, 1797–1883): a pioneer in refrigeration analgesia. Anesthesia 1949;4:10–7.
Arnott J. Practical illustrations of the remedial efficacy of a very low or anesthetic temperature. Lancet 1850;2:257–9.
Rand RW, Rand RP, Eggerding F, et al. Cryolumpectomy for carcinoma of the breast. Surg Gynecol Obstet 1987;165:392–6.
Simmons R, Dowlatshahi K, Singletary SE, Staren ED. Image-guided ablation of breast tumors. Contemp Surg 2002;58:61–71.
Deleted in proof.
Helvie MA, Paramagul C, Oberman HA, Adler DD. Invasive lobular carcinoma: imaging features and clinical detection. Invest Radiol 1993;28:202–7.
Krecke KN, Gisvold JJ. Invasive lobular carcinoma of the breast: mammographic findings and extent of disease at diagnosis in 183 patients. AJR Am J Roentgenol 1993;61:957–60.
Munot K, Dall B, Achuthan R, et al. Role of magnetic resonance imaging in the diagnosis and single-stage surgical resection of invasive lobular carcinoma of the breast. Br J Surg 2002;89:1296–301.
Chopra S, Evans AJ, Pinder SE, et al. Pure mucinous breast cancer—mammographic and ultrasound findings. Clin Radiol 1996;51:421–4.
Wilson TE, Helvie MA, Oberman HA, et al. Pure and mixed mucinous carcinoma of the breast: pathological basis for differences in mammographic appearance. AJR Am J Roentgenol 1995;165:285–9.
Stomper PC, Connolly JL. Mammographic features predicting an extensive intraductal component in early stage infiltrating ductal carcinoma. AJR Am J Roentgenol 1992;158:269–72.
Satake H, Shimamoto K, Sawaki A, et al. Role of ultrasonography in the detection of intraductal spread of breast cancer: correlation with pathologic findings, mammography and MR imaging. Eur Radiol 2000;10:1726–32.
Holland R, Hendriks JH, Verbeek A, et al. Extent, distribution, and mammographic/histologic correlations of breast ductal carcinoma in situ. Lancet 1990;335:519–22.
Tresserra F, Feu J, Grases PJ, et al. Assessment of breast cancer size: sonographic and pathologic correlation. J Clin Ultrasound 1999;27:485–91.
Boetes C, Mus RD, Holland R, et al. Breast tumors: comparative accuracy of MR imaging relative to mammography and US for demonstrating extent. Radiology 1995;197:743–7.
Deleted in proof.
Cady B. Breast cancer in the third millennium. Breast J 2000;6:280–7.
Shepherd JP, Dawber RPR. Wound healing and scarring after cryosurgery. Cryobiology 1984;21:157–69.
Deleted in proof.
Johnson JP. Immunologic aspects of cryosurgery: potential modulation of immune recognition and effector cell maturation. Clin Dermatol 1990;8:39–47.
Gage AA. Cryosurgery for oral and pharyngeal carcinoma. Am J Surg 1969;118:669–72.
Soanes WA, Ablin RJ, Gonder MJ. Remission of metastatic lesions following cryosurgery in prostatic cancer. J Urol 1970;104:154–9.
Ablin RJ. An appreciation and realization of the concept of cryoimmunology. Ablin RJ, eds. Percutaneous Prostate Cryoablation. St. Louis: Quality Medical Publishing Inc, 1995: 136–54.
Bayjoo P, Rees RC, Goepel JR, Jacob G. Natural killer cell activity following cryosurgery of normal and tumour bearing liver in an animal model. J Clin Lab Immunol 1991;35:129–32.
Bilchik AJ, Sarantou T, Wardlaw JC, Ramming KP. Cryosurgery causes a profound reduction in tumor markers in hepatoma and noncolorectal hepatic metastases. Am Surg 1997;63:796–800.
Faraci RP, Bagley DH, Marrone JC, Beazley RM. The effect of curative cryosurgery on the tumor-specific immune response of C57 mice. Cryobiology 1975;12:175–9.
Fazio M, Airoldi M, Gandolfo S, et al. Humoral and cellular immune response to cryosurgery of benign and malignant lesions of the oral cavity (in Italian). Boll Soc Ital Biol Sper 1982;58:412–8.
Faraci RP, Bagley DH, Marrone JC, Beazley RM. In vitro determination of cryosurgical augmentation of tumor immunity. Surgery 1975;77:433–8.
Hoffmann NE, Coad JE, Huot CS, et al. Investigation of the mechanism and the effect of cryoimmunology in the Copenhagen rat. Cryobiology 2001;41:59–68.
Kogel H, Grundmann R, Fohlmeister I, Pichlmaier H. Cryotherapy of rectal cancer. Immunologic results (in German). Zentralbl Chir 1985;110:147–54.
Misao A, Sakata K, Saji S, Kuneida T. Late appearance of resistance to tumor rechallenge following cryosurgery: a study in an experimental mammary tumor of the rat. Cryobiology 1981;18:386–9.
Tsujino M. Activation and regulation of macrophages induced by inoculation of cryodestroyed tumor cells (in Japanese). Osaka Daigaku Shigaku Zasshi 1990;35:180–205.
Wang Z. Cryosurgery in rectal carcinoma—report of 41 cases (in Chinese). Zhonghua Zhong Liu Za Zhi 1989;11:226–7.
Ravindranath MH, Wood TF, Soh D, et al. Cryosurgical ablation of liver tumors in colon cancer patients increases the serum total ganglioside level and then selectively augments antiganglioside IgM. Cryobiology 2002;45:10–21.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Sabel, M.S., Kaufman, C.S., Whitworth, P. et al. Cryoablation of Early-Stage Breast Cancer: Work-in-Progress Report of a Multi-Institutional Trial. Ann Surg Oncol 11, 542–549 (2004). https://doi.org/10.1245/ASO.2004.08.003
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1245/ASO.2004.08.003